
AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To stay invested in Kilroy Realty, you need to believe its West Coast trophy offices and life science assets can stay relevant despite structural office headwinds. The sharp drop in first half 2026 net income and minimal earnings so far this year put more weight on near term leasing and rent trends, while reinforcing the key risk that weaker office demand and lease roll downs could keep profitability under pressure. This update materially heightens that earnings risk.
Against this weaker earnings backdrop, Kilroy’s June 2026 refinancing stands out. The expanded US$1.25 billion revolving credit facility and US$250 million term loan extend maturities into 2030 and 2031, which supports liquidity and gives management more room to handle potential vacancies, capex for ESG upgrades, and asset recycling. For investors watching both catalysts and risks, this balance sheet move sits in sharp contrast to the pressure visible in the income statement.
Yet against this more secure financing picture, investors should still be aware of what happens if re leasing spreads stay weak and upcoming expiries hit occupancy...
Read the full narrative on Kilroy Realty (it's free!)
Kilroy Realty's narrative projects $1.1 billion revenue and $100.3 million earnings by 2029.
Uncover how Kilroy Realty's forecasts yield a $38.29 fair value, a 3% downside to its current price.
Some of the most optimistic analysts were assuming revenue of about US$1.2 billion and earnings of roughly US$131.9 million by 2029, but with Q2’s compressed profits and risks like negative re leasing spreads, you can see how their far more optimistic story might need rethinking compared with the more cautious consensus view.
Explore 3 other fair value estimates on Kilroy Realty - why the stock might be worth just $38.29!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com